The subject of the meeting will be mitochondrial CMT and in particular many of the CMT2A aspects will be discussing by some of the prominent specialists in the field, in particular:
- specific clinical characteristics of CMT2A by Pr Laurent Magy;
- pathophysiological aspects of Charcot Marie Tooth disease concerning MFN2 protein by Dr Julien Cassereau;
- treatment aspects referred to mitochondrial and\or axonal features by Dr Benoit Funalot.
Our project research will be illustrated among the possible leads we may have in order to find a treatment for those kind of neurological disorders: we will keep you updated on the outcome of the day. Stay tuned…
Thanks to Sonia Lauth for having shared with us this important news!